Tatsutoshi Nakahata
2PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Dec 26, 2022
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani
|Aug 31, 2021
CD146 is a potential immunotarget for neuroblastoma.Satoshi Obu, Katsutsugu Umeda, Hiroo Ueno
Pageof 1
Frequent Collaborators
2 joint publications
Katsutsugu Umeda
2 joint publications
Hidefumi Hiramatsu
2 joint publications
Junko Takita
2 joint publications
Souichi Adachi
2 joint publications
Yasuhiko Kamikubo
1 joint publications
Hiroo Ueno
1 joint publications
Keiji Tasaka
1 joint publications
Satoshi Saida
1 joint publications
Itaru Kato
1 joint publications
Hiroshi Sugiyama
